Agilon Health

Agilon Health, Inc. is a healthcare company, enables primary care physicians (PCPs) to be agents in the communities they serve. It provides healthcare for seniors across communities throughout the United States and has created an agilon Platform, which is a Total Care Model for community-based physicians. The firm serves a Total Care Model which focuses exclusively on Medicare and manages the comprehensive healthcare needs of its members through subscription-like member per month arrangements with health plans or directly with the Centers for Medicare and Medicaid services. The company was founded in 2016 and is headquartered in Austin, TX.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Agilon Health reports strong 2022 performance and optimistic growth outlook

Agilon Health had a successful 2022, with strong financial performance and a focus on transforming healthcare through empowering primary care doctors. The company is optimistic about future growth, managing challenges in margins and financial management while leveraging opportunities in partnerships and operational efficiency.

Agilon Health triples Q1 earnings, eyes growth through partnerships

Agilon Health (AGL) delivered robust Q1 2023 results, maintaining outlook and confidence in clinical programs for high-cost patients and new partnerships.
Effective management of costs and revenues, alongside strategic acquisitions and partnerships, underpin the company's growth trajectory.
Challenges include margin impacts from external factors and managing costs associated with market expansion, balanced by opportunities in network growth and market transition.
The company's performance, strengths, challenges, and opportunities collectively shape its strategic direction towards sustained growth and operational excellence.

Agilon Health excels in Q2 2023, eyes growth opportunities

Agilon Health's strong financial performance in Q2 2023 underscores its operational excellence and growth potential. While challenges like revenue projections and medical margin variations exist, the company's strategic focus on risk adjustment and payer partnerships presents significant opportunities for future success.

Agilon Health reports strong Q3 performance, eyes growth opportunities

Agilon Health's Q3 2023 performance reflects robust growth in partner markets and revenue, supported by a unique model driving clinical and financial success.
While facing challenges in cash flow and benefit pullbacks, the company is well-positioned to leverage opportunities for growth and operational enhancement in '24.
Strategic decisions like selling the Hawaii business and focusing on core markets demonstrate a commitment to sustainable growth and operational efficiency.

Agilon Health addresses challenges, focuses on growth opportunities in 2024

Agilon Health faces challenges with medical margins but is making progress on their 2024 performance action plan to drive improvement.
The company is focusing on data visibility, quality partnerships, and efficiency gains to navigate the dynamic utilization environment and achieve growth.
Despite higher cash burn in 2024, Agilon anticipates positive cash flow from 2025 onwards if they meet their guidance and address payer negotiations.
Opportunities lie in a measured growth approach, cohort progression, and tuning payer arrangements to reflect the value provided by Agilon's services.

Agilon Health reports strong Q1 growth, navigates healthcare challenges

Agilon Health's Q1 '24 performance showcased growth in membership, revenue, medical margin, and adjusted EBITDA, despite challenges in cost trends and utilization.
The company's strategic focus on value-based care partnerships, data analytics, and operational efficiency positions them well for future growth and profitability.
While facing challenges in cost management and contract negotiations, Agilon Health is actively pursuing opportunities in sustainable payer contracts, technology enhancements, and benefit expansions.

Agilon Health reports strong Q2 performance and strategic growth outlook

Agilon Health's Q2 2024 earnings call reflects robust performance, operational strengths, strategic challenges, and growth opportunities in the evolving healthcare landscape.
The company's focus on refining payer relationships, enhancing data visibility, and driving operational efficiency positions it well for sustained success and market expansion.
Despite facing financial challenges and navigating payer dynamics, Agilon Health's proactive approach to innovation and leadership changes signals a commitment to long-term growth and value creation.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Agilon Health, Inc. engages in providing healthcare services. It also provides the technology, people, capital, process, and access to a peer network of primary care physicians. The company was founded by Ronald A. Williams and Veeral Desai in 2016 and is headquartered in Austin, TX.

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced results for the fourth quarter and fiscal year ended December 31, 2023. “agilon is navigating through a complex transition period for the Medicare Advantage industry and for our company, and we are taking significant actions to help mitigate the impact of this evolving environment and strengthening our reserves,” said Steve Sell, chief.

agilon health Reports Fourth Quarter 2023 Results

Beyond analysts' top -and-bottom-line estimates for Agilon (AGL), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.

Seeking Clues to Agilon (AGL) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will participate in the 44th Annual Cowen Health Care Conference including a fireside chat on Tuesday, March 5 at 12:50 PM Eastern Time. Interested investors and other parties may listen to a simultaneous webcast of the presentation by visiting the “Events & Presentations” section of agilon health's investor relations websi.

agilon health to Participate in the 44th Annual Cowen Health Care Conference

Agilon (AGL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Agilon Health (AGL) to Report a Decline in Earnings: What to Look Out for

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the fourth quarter and full year 2023 after the market closes on Tuesday, February 27, 2023, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (833) 470-1428 for U.S. participants and +1 (929) 526-1599 for.

agilon health Sets Date to Report Fourth Quarter and Full Year 2023 Financial Results

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced today that Benjamin Kornitzer, M.D., will assume a strategic role as special advisor to the company and will transition from his role as chief medical officer (CMO) effective March 1, 2024. agilon health has initiated a comprehensive search process to identify a new CMO. Until a successor is named, Karthik Rao, M.D., senior medical dir.

agilon health Announces Chief Medical Officer Transition

Bilibili

IHS Holding Ltd

Lithium Americas Corp

Relay Therapeutics, Inc.

Seabridge Gold

Wheels Up Experience

This year is going to offer a lot of opportunities for risk seeking investors. The world of penny stocks is well known to be speculative and is usually the domain of investors possessing a risk seeking profile.

The 7 Best Penny Stocks for 200% Returns

NEW YORK , Jan. 30, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of agilon health, inc. ("Agilon Health" or the "Company") (NYSE: AGL).

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of agilon health, inc. - AGL

RADNOR, Pa. , Jan. 22, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Agilon Health, Inc. (NYSE: AGL) ("Agilon").

Agilon Investigation: Kessler Topaz Meltzer & Check, LLP is Investigating Securities Fraud Claims Against Agilon Health, Inc. (NYSE: AGL)

LOS ANGELES, CA / ACCESSWIRE / January 21, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of agilon health, inc. ("agilon" or "the Company") (NYSE:AGL) for violations of the securities laws.

SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against agilon health, inc. and Encourages Investors with Losses to Contact the Firm

AUSTIN, Texas--(BUSINESS WIRE)--Insert at end of the first paragraph of release issued November 16, 2023: The statements contained in this document are solely those of the authors and do not necessarily reflect the view or policies of CMS. The authors assume responsibility for the accuracy and completeness of the information contained in this document. The updated release reads: PEER-REVIEWED STUDY FINDS PALLIATIVE CARE PROGRAM UNDER AGILON HEALTH'S VALUE-BASED MODEL SIGNIFICANTLY IMPROVED PATI.

INSERTING and REPLACING Peer-Reviewed Study Finds Palliative Care Program Under agilon health's Value-Based Model Significantly Improved Patient Outcomes

RADNOR, Pa.--(BUSINESS WIRE)-- #classaction--The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Agilon Health, Inc. (NYSE: AGL) (“Agilon”). On January 5, 2024, Agilon announced revised guidance expectations for 2023 revenue and stated that such revisions were due to an increase in medical expenses. The company also announced that its CFO would step down in 2024. Following this news, Agil.

AGL Investigation: Kessler Topaz Meltzer & Check, LLP is Investigating Securities Fraud Claims Against Agilon Health, Inc. (NYSE: AGL)

LOS ANGELES, CA / ACCESSWIRE / January 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of agilon health, inc. ("agilon" or "the Company") (NYSE:AGL) for violations of the securities laws.

IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against agilon health, inc. and Encourages Investors with Losses to Contact the Firm

AerSale Corp

Core Laboratories Inc

In the investment space, uncovering stocks to sell with potential pitfalls is as crucial as identifying opportunities. This comprehensive review zooms in on the recent moves of three prominent companies that have sent ripples through the market.

February Risk Alert: 3 Stocks to Unload Now to Protect Your Portfolio

The provider of support services for primary care physicians anticipates medical margins for fiscal 2023 of between $340 million and $360 million, down from an earlier forecast of $455 million to $470 million.

Agilon Health Stocks Sinks 35%. It Slashes Margin Guidance on Higher Medical Costs.

Shares of Agilon Health Inc. AGL, -0.25% were indicated down more than 1% in Friday's premarket, after the health care services company lowered its 2023 margin outlook, citing higher costs, but provided an upbeat 2024 outlook. “Higher-than-expected costs became visible to us in mid-December during the November close process given updated data from health plans and will impact our FY2023 medical margins,” said Chief Executive Steve Sell.

Agilon Health cuts 2023 revenue, medical margin outlook but provides upbeat 2024 view

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, Inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that Timothy Bensley has informed the company of his intent to retire from his position as Chief Financial Officer (CFO) during 2024, which agilon expects to take place within the next nine months. The search for a new CFO has been initiated, and Bensley has agreed to remain as CFO through this process and serve in a consulting r.

agilon health Announces Tim Bensley to Retire as CFO

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced revised guidance expectations for 2023, reflecting higher-than-expected costs, and provided an initial outlook for 2024. During 2023, agilon health experienced an increase in medical expenses attributable to higher-than-expected specialist visits, Part B drugs, outpatient surgeries, and supplemental benefits, partially offset by lower.

agilon health Provides 2023 Guidance Update, Initial 2024 View

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health in our communities, announced that it will participate in the 42nd Annual J.P. Morgan Healthcare Conference including a fireside chat presentation on Tuesday, January 9 at 1:30 PM Eastern Time. Interested investors and other parties may listen to a simultaneous webcast of the presentation by visiting the “Events & Presentations” section of agilon health's investor r.

agilon health to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

agilon health's full-year outlook caused its stock to fall sharply, raising concerns about the sustainability of its business model. While the company reported a 71% increase in revenue and a rise in Medicare Advantage membership, its gross profit growth doesn't hold up. A $5 billion market cap appears too high, considering agilon's low medical margins.

agilon health: High Growth But Unsustainable Economics

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced the publication of new peer-reviewed data examining the impact of its full-risk, Total Care Model (agilon model) among both Medicare Advantage (MA) and ACO REACH patients enrolled in an innovative palliative care program. The first-of-its-kind study, published in the Journal of Pain and Symptom Management, evaluated a scaled primary ca.

Peer-Reviewed Study Finds Palliative Care Program Under agilon health's Value-Based Model Significantly Improved Patient Outcomes

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health in our communities, announced that it will participate in the 5th Annual Wolfe Research Healthcare Conference, including a fireside chat presentation on Tuesday, November 14 at 10:15 AM Eastern Time. Interested investors and other parties may listen to a simultaneous webcast of the presentations by visiting the “Events & Presentations” section of agilon health's inv.

agilon health to Participate in Wolfe Research Healthcare Conference

Start Time: 16:30 January 1, 0000 5:29 PM ET agilon health, inc. (NYSE:AGL ) Q3 2023 Earnings Conference Call November 02, 2023, 16:30 PM ET Company Participants Steve Sell - CEO Tim Bensley - CFO Matthew Gillmor - VP, IR Conference Call Participants Lisa Gill - JPMorgan Justin Lake - Wolfe Research Stephen Baxter - Wells Fargo Gary Taylor - Cowen Jailendra Singh - Truist Securities George Hill - Deutsche Bank Whit Mayo - Leerink Partners Adam Ron - Bank of America Jamie Perse - Goldman Sachs Elizabeth Anderson - Evercore ISI Thomas Kelliher - RBC Capital Markets Jack Wallace - Guggenheim Operator Hello, everyone.

agilon health, inc. (AGL) Q3 2023 Earnings Call Transcript

Although the revenue and EPS for Agilon (AGL) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Compared to Estimates, Agilon (AGL) Q3 Earnings: A Look at Key Metrics

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced results for the third quarter ended September 30, 2023. “Momentum across our business remains strong, driven by the power of agilon's physician network and platform to improve patient outcomes across the Medicare Advantage and ACO REACH populations,” said Steve Sell, chief executive officer. “Our decision to sell MDX Hawaii and focus o.

News for Agilon Health Stock (AGL)